Group II Intron Reverse Transcriptase Crystal Structure
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a lack of high-resolution structural information about group II intron reverse transcriptases (RTs), which are crucial for understanding their biochemical and biotechnological significance.
Innovation Solution
A crystal structure of a non-LTR-retroelement reverse transcriptase, specifically a bacterial group II intron RT, is determined in complex with a template and primer oligonucleotide and incoming dNTP, providing insights into its structural features and functional mechanisms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of information
If high-resolution structural information is obtained about group II intron reverse transcriptases, then understanding of biochemical and biotechnological significance is improved, but the complexity of structural determination and analysis increases
Solution Approach 1:
The crystal structure is divided into distinct functional domains (fingers, palm, thumb) with specific sequence blocks (RT1-7) and insertions (RT2a, RT3a). This segmentation allows systematic analysis of each region's contribution to function, making the complex structure manageable and interpretable for understanding biochemical mechanisms.
Solution Approach 2:
The patent uses crystallography as an intermediary method to obtain structural information that cannot be directly observed. The crystal structure serves as a mediator between the enzyme's functional properties and our understanding, enabling indirect analysis of biochemical mechanisms through static structural data.
2Reliability
If the fingers region is enlarged with distinctive insertions (RT2a, RT3a) and N-terminal extension, then fidelity and processivity are improved, but the overall enzyme size and complexity increase
Solution Approach 1:
The patent identifies specific local regions (fingers domain, palm domain, thumb domain) with distinct sequence blocks and insertions that confer specific functions. The RT2a and RT3a insertions in the fingers region, along with the N-terminal extension containing RT0, provide localized functional enhancements for fidelity and processivity without requiring complete redesign of the entire enzyme.
Solution Approach 2:
The enzyme structure exhibits nested organization where functional insertions (RT2a, RT3a) are embedded within the conserved sequence blocks (RT1-7), and the N-terminal extension with RT0 is integrated into the fingers domain. This nested arrangement allows multiple functional elements to coexist within a compact framework, achieving high fidelity without proportional increase in overall complexity.
3Adaptability or versatility
If non-LTR-retroelement RTs are studied in detail, then biotechnological applications are improved, but the amount of research and development time required increases
Solution Approach 1:
The patent identifies universal structural features (conserved sequence blocks RT1-7, common domain architecture) that are shared across diverse non-LTR-retroelement RTs including group II intron RTs, bacterial RTs, and retrotransposon RTs. This universality allows findings from one system to be applied to others, expanding biotechnological applications while reducing the time needed to study each individual system separately.
Data Source
AI summary
A crystal structure of a Non-LTR-retroelement reverse transcriptase and methods of using the same to identify enzymes with improved activity are provided. Mutant reverse transcriptase enzymes and methods of using the same are also provided.